InhaleRX snags $38.5M in funding from VC biotech funder Clendon
InhaleRX is set to go ahead with clinical trials after Victorian VC firm Clendon handed IRX nearly $40M in cash.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
AWH | Ann:Results of Meeting (Price Sensitive) | 30/07/21 | 0 | 411 | |||
|
|||||||
AWH | Ann:Intended Delisting Date (Price Sensitive) | 26/07/21 | 0 | 481 | |||
|
|||||||
AWH | Ann:Covid Arrangements | 21/07/21 | 0 | 431 | |||
|
|||||||
AWH | Ann:Notice of General Meeting (Price Sensitive) | 01/07/21 | 0 | 518 | |||
|
|||||||
AWH | Ann:Proxy Form | 01/07/21 | 0 | 467 | |||
|
|||||||
AWH | Ann:Market Update and Intnetion to Delist (Price Sensitive) | 18/06/21 | 0 | 508 | |||
|
|||||||
AWH | Ann:Down Turn In Business (Price Sensitive) | 05/05/21 | 0 | 655 | |||
|
|||||||
AWH | Ann:Suspension for Official Quotation - Failure to lodge Half Yearly Financial Statements - 31... | 19/03/21 | 0 | 789 | |||
|
See All Discussions